Proactive infliximab optimisation using a pharmacokinetic dashboard versus standard of care in patients with Crohns disease: study protocol for a randomised, controlled, multicentre, open-label study (the OPTIMIZE trial)
Proactive infliximab optimisation using a pharmacokinetic dashboard versus standard of care in patients with Crohns disease: study protocol for a randomised, controlled, multicentre, open-label study (the OPTIMIZE trial)